Sernova (SVA) Competitors

Fennec Pharmaceuticals (TSE:FRX) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk, community ranking and valuation.

Which has more risk and volatility, FRX or SVA?

Fennec Pharmaceuticals has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500. Comparatively, Sernova has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500.

Which has better earnings and valuation, FRX or SVA?

Fennec Pharmaceuticals has higher revenue and earnings than Sernova. Fennec Pharmaceuticals is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fennec Pharmaceuticals	C$34.86M	5.95	-C$800.44K	-C$0.06	-182.27
Sernova	N/A	N/A	-C$35.70M	-C$0.10	-1.59

Is FRX or SVA more profitable?

Sernova has a net margin of 0.00% compared to Fennec Pharmaceuticals' net margin of -2.30%. Sernova's return on equity of 473.85% beat Fennec Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fennec Pharmaceuticals	-2.30%	29.94%	8.88%
Sernova	N/A	473.85%	-119.26%

Does the MarketBeat Community believe in FRX or SVA?

Fennec Pharmaceuticals received 93 more outperform votes than Sernova when rated by MarketBeat users. However, 91.67% of users gave Sernova an outperform vote while only 69.80% of users gave Fennec Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Fennec Pharmaceuticals	Outperform Votes 104 69.80%	Underperform Votes 45 30.20%
Sernova	Outperform Votes 11 91.67%	Underperform Votes 1 8.33%

Does the media favor FRX or SVA?

In the previous week, Fennec Pharmaceuticals had 4 more articles in the media than Sernova. MarketBeat recorded 4 mentions for Fennec Pharmaceuticals and 0 mentions for Sernova. Fennec Pharmaceuticals' average media sentiment score of 0.34 beat Sernova's score of 0.00 indicating that Fennec Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Fennec Pharmaceuticals	Neutral
Sernova	Neutral

Do institutionals & insiders hold more shares of FRX or SVA?

52.8% of Fennec Pharmaceuticals shares are held by institutional investors. Comparatively, 0.1% of Sernova shares are held by institutional investors. 16.2% of Fennec Pharmaceuticals shares are held by company insiders. Comparatively, 12.1% of Sernova shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Do analysts recommend FRX or SVA?

Sernova has a consensus price target of C$2.00, suggesting a potential upside of 1,112.12%. Given Sernova's higher probable upside, analysts plainly believe Sernova is more favorable than Fennec Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fennec Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Sernova	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Summary

Fennec Pharmaceuticals beats Sernova on 10 of the 17 factors compared between the two stocks.